ONCY:NASDAQ
Oncolytics Biotech Inc
$ 0.84
arrow_downward
-1.55%(-0.013) 1D
$ 0.84
arrow_downward
-0.38% (-0.0032)bedtimeAfter hours
Closed: 9-р сарын 4, 16:00:00 (GMT-4) · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$ 0.84
High
$ 0.85
Low
$ 0.83
Mkt. cap
107.52 сая
Avg. vol.
710.35 мян
Volume
463.71 мян
52-wk high
$ 1.51
52-wk low
$ 0.73
Beta
1.15
Shares outstanding
127.51 сая
No. of employees
29
Open
$ 0.84
High
$ 0.85
Low
$ 0.83
Mkt. cap
107.52 сая
Avg. vol.
710.35 мян
Volume
463.71 мян
52-wk high
$ 1.51
52-wk low
$ 0.73
Beta
1.15
Shares outstanding
127.51 сая
No. of employees
29
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 сарын өмнө
ONCY Q3 2025 Earnings: EPS Miss by 43.5% as Net Loss Widens, Stock Gains 3.75% - Revenue Recognition Risk
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc